Boston Scientific (BSX) Research & Development (2009 - 2026)
Boston Scientific (BSX) posted quarterly Research & Development of $554.0 million for Q2 2026, up 5.32% year-over-year from $526.0 million in Q2 2025, and up 7.36% on a QoQ basis from $516.0 million in Q1 2026.
Boston Scientific (BSX) Research & Development (2009 - 2026) Analysis & Trends
Boston Scientific has reported Research & Development for 18 years, with the latest figure at $554.0 million in Q2 2026.
- Research & Development for Q2 2026 came in at $554.0 million, up 5.32% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.2 billion (up 17.33% YoY), and the FY2025 annual result was $2.1 billion, up 27.06% from the prior year.
- Research & Development grew to $554.0 million in Q2 2026, from $516.0 million in the prior quarter.
- Over five years, Research & Development peaked at $569.0 million in Q4 2025 and troughed at $319.0 million in Q1 2022.
- A 5-year average of $415.3 million and a median of $374.5 million in 2024 frame the typical range for Research & Development.
- The widest annual swing landed in 2022, when Research & Development advanced 3.12%; it then soared 37.34% in 2025.
- A 5-year view of Research & Development shows it stood at $330.0 million in 2022, then climbed by 10.0% to $363.0 million in 2023, then grew by 26.45% to $459.0 million in 2024, then grew by 23.97% to $569.0 million in 2025, then slipped by 2.64% to $554.0 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $554.0 million in Q2 2026, $516.0 million in Q1 2026, and $569.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | -1.02 Bn |
| 10 | Steris | 22.74 Bn | 22.25 Bn | 684.20 Mn | 28.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 554.00 Mn |
| Mar 31, 2026 | 516.00 Mn |
| Dec 31, 2025 | 569.00 Mn |
| Sep 30, 2025 | 514.00 Mn |
| Jun 30, 2025 | 526.00 Mn |
| Mar 31, 2025 | 443.00 Mn |
| Dec 31, 2024 | 459.00 Mn |
| Sep 30, 2024 | 407.00 Mn |
| Jun 30, 2024 | 383.00 Mn |
| Mar 31, 2024 | 366.00 Mn |
| Dec 31, 2023 | 363.00 Mn |
| Sep 30, 2023 | 356.00 Mn |
| Jun 30, 2023 | 359.00 Mn |
| Mar 31, 2023 | 337.00 Mn |
| Dec 31, 2022 | 330.00 Mn |
| Sep 30, 2022 | 339.00 Mn |
| Jun 30, 2022 | 335.00 Mn |
| Mar 31, 2022 | 319.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 310.00 Mn |